UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Zions Bancorporation N.A.

Zions Bancorporation N.A. lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 16.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,093 shares of the healthcare conglomerate's stock after buying an additional 2,503 shares during the period. UnitedHealth Group makes up 0.6% of Zions Bancorporation N.A.'s holdings, making the stock its 23rd biggest position. Zions Bancorporation N.A.'s holdings in UnitedHealth Group were worth $9,153,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the business. NewSquare Capital LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $25,000. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter worth $30,000. Promus Capital LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter valued at about $32,000. RPg Family Wealth Advisory LLC acquired a new stake in UnitedHealth Group during the third quarter worth about $37,000. Finally, Pillar Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $40,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the business's stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company's stock, valued at $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. 0.33% of the stock is currently owned by company insiders.

Remove Ads

UnitedHealth Group Stock Up 0.4 %

Shares of UNH stock traded up $2.11 on Friday, reaching $517.83. 1,193,911 shares of the stock were exchanged, compared to its average volume of 4,262,706. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $473.66 billion, a price-to-earnings ratio of 33.38, a PEG ratio of 1.37 and a beta of 0.62. The business's 50 day moving average price is $508.70 and its 200 day moving average price is $545.16.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the company earned $5.83 EPS. The business's quarterly revenue was up 6.8% on a year-over-year basis. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.62%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's payout ratio is currently 54.19%.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on UNH shares. Barclays lowered their price objective on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research report on Friday, January 17th. Deutsche Bank Aktiengesellschaft raised their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a research report on Tuesday, December 3rd. Hsbc Global Res raised shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. Truist Financial lowered their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research report on Monday, January 6th. Finally, Stephens raised their price target on UnitedHealth Group from $605.00 to $675.00 and gave the stock an "overweight" rating in a research report on Thursday, December 5th. Twenty analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of "Buy" and an average price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.